BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7227717)

  • 1. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
    Inoue K; Fujimoto S; Ogawa M
    Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S; Tashiro T; Ogawa M
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
    Fujimoto S; Ogawa M
    Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on the antitumor activity and the bone marrow toxicity of 1-(beta-D-glucopyranosyl)-3-(2-chloroethyl)-3-nitrosourea and 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose.
    Aoshima M; Sakurai Y
    Gan; 1977 Apr; 68(2):247-50. PubMed ID: 892299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
    Fox PA; Panasci LC; Schein PS
    Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of experimental studies on nitrosourea derivatives in Japan.
    Tsukagoshi S
    Recent Results Cancer Res; 1980; 70():107-17. PubMed ID: 7355242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
    Fujimoto S; Ogawa M; Hoshino A
    Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
    Kato T; Ota K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1354-62. PubMed ID: 6223585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
    Akaike Y; Arai Y; Taguchi H; Satoh H
    Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
    Fujimoto S; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activities of 3-(methyl-alpha-D-glucopyranos-6-YL)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Sekido S; Ninomiya K; Sekine J; Ueno S
    Gan; 1976 Feb; 67(1):137-9. PubMed ID: 1269854
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
    Shimizu F; Arakawa M
    Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of nitrosourea murine bone marrow toxicity with deoxyribonucleic acid alkylation and chromatin binding sites.
    Green D; Tew KD; Hisamatsu T; Schein PS
    Biochem Pharmacol; 1982 May; 31(9):1671-9. PubMed ID: 7104031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
    Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
    Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the biological and biochemical properties of 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose.
    Nagourney RA; Fox P; Schein PS
    Cancer Res; 1978 Jan; 38(1):65-8. PubMed ID: 145314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.
    Shimizu F; Arakawa M
    Gan; 1975 Apr; 66(2):149-54. PubMed ID: 1150007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
    Fujimoto S; Wang Y; Ogawa M
    Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.